M
IMEPro
M77.10 Musculoskeletal Parent Code
Updated March 2026

Lateral epicondylitis, unspecified elbow

ICD-10 Code: M77.10 · Body Part: Elbow

QME Evaluation Process

Elbow examination including Cozen's test, grip strength testing, elbow ROM. UE impairment based on elbow ROM loss and grip strength deficit.

Typical Impairment Rating

3-8% UE (2-5% WPI)

AMA Guides Edition

5th Edition

Common Treatments

+ Physical therapy
+ Counterforce bracing
+ Corticosteroid injection
+ PRP injection
+ Surgical debridement

Related Conditions

Body Part Guide

Elbow Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Lateral epicondylitis, unspecified elbow

Find a QME Specialist

Browse QME-certified physicians who evaluate lateral epicondylitis, unspecified elbow and related elbow conditions in California.

Browse Physical Medicine & Rehabilitation Physicians →

Frequently Asked Questions

What is Lateral epicondylitis, unspecified elbow (M77.10)?

Lateral epicondylitis, unspecified elbow is an ICD-10 diagnosis code (M77.10) classified under Musculoskeletal conditions. It affects the Elbow and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is M77.10 rated for impairment?

The typical whole person impairment (WPI) range for Lateral epicondylitis, unspecified elbow is 3-8% UE (2-5% WPI). The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for M77.10?

Elbow examination including Cozen's test, grip strength testing, elbow ROM. UE impairment based on elbow ROM loss and grip strength deficit.

What treatments are common for Lateral epicondylitis, unspecified elbow?

Common treatments for Lateral epicondylitis, unspecified elbow include Physical therapy, Counterforce bracing, Corticosteroid injection, PRP injection, Surgical debridement. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.